TABLE 1

Demographics, Neurology, HTLV-1 Virology, and Immunology

Subject no. in analysisAge (y)SexEthnicityDuration disease (y)Mobility aid10-m TW (s)PETMRIDWIHTLV-1* proviral loadCD8 DRDisease
#1 HAMs155FemaleCaucasian19Frame36655 min4.959Severe HAM progressing
#2 HAMs248FemaleCaucasian5Frame10917.447Severe HAM progressing
#3 HAMmo66FemaleAfro-Caribbean81 stick14.50 minx3.842Moderate HAM stable
#4 HAMmi59FemaleAfro-Caribbean2Unaided11.57.932Mild HAM stable
#5 HAMmo54MaleAfro-Caribbean13Elbow crutches24.710.532Moderate HAM slow progression
#6 Asym157FemaleAfro-CaribbeanN/AUnaided6.56.427Asymptomatic
#7 Asym257MaleAfro-CaribbeanN/AUnaided6.62.617Asymptomatic
  • * HTLV-1 DNA copies per 100 PBMCs.

  • 10-m TW = time taken to walk 10 m on the flat; CD8 DR = % CD8 lymphocytes expressing human leukocyte antigen–antigen D related; HAMs1 = patient 1, severe HAM; HAMs2 = patient 2, severe HAM; HAMmo = patient 5, moderate HAM; HAMmi = patient 4, mild HAM; Asym1 = patient 6, asymptomatic; Asym 2 = patient 7, asymptomatic.